Harnessing nanomedicine to potentiate the chemo-immunotherapeutic effects of doxorubicin and alendronate co-encapsulated in pegylated liposomes

John Maher

Harnessing nanomedicine to potentiate the chemo-immunotherapeutic effects of doxorubicin and alendronate co-encapsulated in pegylated liposomes

Comprehensive Cancer Centre

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Pharmaceutics
Publication status	Published - 9 Nov 2023

Cite this

@article{bc1b7bfa740946d5bcb812a1caf66589,

title = "Harnessing nanomedicine to potentiate the chemo-immunotherapeutic effects of doxorubicin and alendronate co-encapsulated in pegylated liposomes",

author = "John Maher",

year = "2023",

month = nov,

day = "9",

language = "English",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute",

}

Harnessing nanomedicine to potentiate the chemo-immunotherapeutic effects of doxorubicin and alendronate co-encapsulated in pegylated liposomes

Other files and links

Cite this